CME Group Inc. Reports All-Time Record Annual Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for 2024
CME Group reported record financial results for 2024, with total revenue reaching $6.1 billion, up 10% from the previous year. The company achieved record annual average daily volume across every asset class, with notable performance in interest rates, agricultural, foreign exchange, and metals markets.
Fourth-quarter 2024 performance showed revenue of $1.5 billion and operating income of $947 million. Net income was $875 million with diluted earnings per share of $2.40. On an adjusted basis, Q4 net income was $919 million with diluted earnings per share of $2.52.
The company declared total dividends of $3.8 billion during 2024, including an annual variable dividend of $2.1 billion. A first-quarter 2025 dividend of $1.25 per share was announced, representing a 9% increase from the previous $1.15 per share.
CME Group ha riportato risultati finanziari record per il 2024, con un fatturato totale che ha raggiunto 6,1 miliardi di dollari, in aumento del 10% rispetto all'anno precedente. L'azienda ha raggiunto un volume medio giornaliero annuale record in tutte le classi di attivi, con prestazioni notevoli nei mercati dei tassi d'interesse, agricoli, delle valute e dei metalli.
Le performance del quarto trimestre del 2024 hanno mostrato un fatturato di 1,5 miliardi di dollari e un reddito operativo di 947 milioni di dollari. L'utile netto è stato di 875 milioni di dollari con utili diluiti per azione di 2,40 dollari. Su base rettificata, l'utile netto del quarto trimestre è stato di 919 milioni di dollari con utili diluiti per azione di 2,52 dollari.
L'azienda ha dichiarato dividendi totali di 3,8 miliardi di dollari durante il 2024, inclusi un dividendo variabile annuale di 2,1 miliardi di dollari. È stato annunciato un dividendo per il primo trimestre del 2025 di 1,25 dollari per azione, che rappresenta un aumento del 9% rispetto all'attuale dividendo di 1,15 dollari per azione.
CME Group reportó resultados financieros récord para 2024, con ingresos totales que alcanzaron 6.1 mil millones de dólares, un aumento del 10% respecto al año anterior. La compañía logró un volumen promedio diario anual récord en todas las clases de activos, con un rendimiento notable en los mercados de tasas de interés, agrícolas, de divisas y de metales.
El desempeño del cuarto trimestre de 2024 mostró ingresos de 1.5 mil millones de dólares y un ingreso operativo de 947 millones de dólares. El ingreso neto fue de 875 millones de dólares con ganancias diluidas por acción de 2.40 dólares. En términos ajustados, el ingreso neto del cuarto trimestre fue de 919 millones de dólares con ganancias diluidas por acción de 2.52 dólares.
La compañía declaró dividendos totales de 3.8 mil millones de dólares durante 2024, incluyendo un dividendo variable anual de 2.1 mil millones de dólares. Se anunció un dividendo del primer trimestre de 2025 de 1.25 dólares por acción, lo que representa un aumento del 9% respecto al anterior dividendo de 1.15 dólares por acción.
CME 그룹은 2024년 기록적인 재무 결과를 보고했으며, 총 수익이 61억 달러에 달해 전년 대비 10% 증가했습니다. 이 회사는 모든 자산 클래스에서 연간 평균 일일 거래량의 기록을 달성했으며, 금리, 농업, 외환 및 금속 시장에서 두드러진 성과를 보였습니다.
2024년 4분기 실적은 수익이 15억 달러였고 운영 소득은 9억 4700만 달러였습니다. 순이익은 8억 7500만 달러였으며 희석 주당 순이익은 2.40 달러였습니다. 조정 기준으로 4분기 순이익은 9억 1900만 달러였으며 희석 주당 순이익은 2.52 달러였습니다.
회사는 2024년 동안 총 38억 달러의 배당금을 선언했으며, 여기에는 21억 달러의 연간 변동 배당금이 포함됩니다. 2025년 1분기 주당 1.25 달러의 배당금이 발표되었으며, 이는 이전의 1.15 달러에서 9% 증가한 것입니다.
CME Group a annoncé des résultats financiers records pour 2024, avec un chiffre d'affaires total atteignant 6,1 milliards de dollars, en hausse de 10 % par rapport à l'année précédente. L'entreprise a réalisé un volume moyen quotidien annuel record dans toutes les classes d'actifs, avec des performances notables sur les marchés des taux d'intérêt, agricoles, des changes et des métaux.
Les performances du quatrième trimestre 2024 ont montré un chiffre d'affaires de 1,5 milliard de dollars et un revenu opérationnel de 947 millions de dollars. Le bénéfice net était de 875 millions de dollars avec un bénéfice dilué par action de 2,40 dollars. Sur une base ajustée, le bénéfice net du quatrième trimestre était de 919 millions de dollars avec un bénéfice dilué par action de 2,52 dollars.
L'entreprise a déclaré des dividendes totaux de 3,8 milliards de dollars en 2024, y compris un dividende variable annuel de 2,1 milliards de dollars. Un dividende de 1,25 dollar par action pour le premier trimestre 2025 a été annoncé, représentant une augmentation de 9 % par rapport à l'ancien dividende de 1,15 dollar par action.
CME Group berichtete über rekordverdächtige finanzielle Ergebnisse für 2024, mit einem Gesamtumsatz von 6,1 Milliarden Dollar, was einem Anstieg von 10% im Vergleich zum Vorjahr entspricht. Das Unternehmen erzielte ein rekordverdächtiges jährliches durchschnittliches Tagesvolumen in allen Anlageklassen, mit bemerkenswerten Leistungen in den Märkten für Zinssätze, Agrarprodukte, Devisen und Metalle.
Die Leistung im vierten Quartal 2024 zeigte einen Umsatz von 1,5 Milliarden Dollar und ein Betriebsergebnis von 947 Millionen Dollar. Der Nettogewinn betrug 875 Millionen Dollar mit einem verwässerten Gewinn pro Aktie von 2,40 Dollar. Auf adjustierter Basis betrug der Nettogewinn im vierten Quartal 919 Millionen Dollar mit einem verwässerten Gewinn pro Aktie von 2,52 Dollar.
Das Unternehmen erklärte insgesamt 3,8 Milliarden Dollar an Dividenden im Jahr 2024, einschließlich einer jährlichen variablen Dividende von 2,1 Milliarden Dollar. Eine Dividende von 1,25 Dollar pro Aktie für das erste Quartal 2025 wurde angekündigt, was einem Anstieg von 9% gegenüber der vorherigen Dividende von 1,15 Dollar pro Aktie entspricht.
- Record annual revenue of $6.1 billion, up 10% year-over-year
- Volume growth across all asset classes with new records in multiple markets
- Q4 revenue increased 6% with improved adjusted net income and earnings
- 9% increase in quarterly dividend to $1.25 per share
- Strong cash position of $3.1 billion with $3.4 billion in debt
- Q4 2024 average daily volume flat compared to Q4 2023
- Slight decrease in cash and cash equivalents from $2,912.0M to $2,892.4M year-over-year
Insights
CME Group's record-breaking 2024 performance showcases the company's dominant position in global derivatives markets and its ability to capitalize on market volatility. The 10% revenue growth to
The company's clearing and transaction fees, which generated
International expansion continues to be a key growth driver, with non-U.S. average daily volume increasing
The company's capital return strategy remains highly attractive to shareholders, with
The strong performance across interest rates, agricultural, and FX products demonstrates CME's important role in global risk management, particularly during periods of economic uncertainty. The company's strategic partnership with Google Cloud positions it well for continued technological innovation and operational efficiency improvements.
- Record revenue of
$6.1 billion 10%
The company reported revenue of
Total revenue for full-year 2024 was
"In 2024, CME Group had its best year ever, generating record annual average daily volume, revenue, adjusted operating income, adjusted net income and adjusted earnings per share," said Terry Duffy, CME Group Chairman and Chief Executive Officer. "With volume growth across every asset class, we hit new records in interest rates, including
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart following the financial statements. |
Fourth-quarter 2024 average daily volume (ADV) was 25.5 million contracts, in line with fourth-quarter 2023, including non-
Clearing and transaction fees revenue for fourth-quarter 2024 totaled
As of December 31, 2024, the company had approximately
CME Group will hold a Q&A conference call to discuss fourth-quarter 2024 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at investor.cmegroup.com. An archived recording will be available for up to two months after the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and
Statements in this document that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing innovative and competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and derive revenues that are commensurate with our efforts and expectations, our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to manage variable costs relating to CME Group's transition to the Google Cloud and Google Cloud platform and minimize duplicative costs during the transition between maintaining the on-premise environment and the Google Cloud environment; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers, as well as the impact of tariffs and tax policy changes, restrictions on our ability to offer CME Group products and services in specific geographies or to specific customers or limitations or changes in underlying/physical product flows across geographies; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by our third-party providers and third party providers that our clients and third-parties rely on; our reliance on third-party distribution partners, including independent software vendors (ISVs), Futures Commission Merchants (FCMs), introducing brokers, broker-dealers around the world, regulatory reporting and data distributors and platform operators, and other partners, for facilitating trading and for market data information, and potential impacts from changes in their business models and priorities; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and market data and order transaction traffic across the entire trade cycle and the ability to implement enhancements without failure or degradation of the performance of our trading and clearing systems and meeting our regulatory reporting obligations; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices LL) in index services, our primary business and distribution partners' actions and our partnership with Google, including our ability to manage the successful implementation of our agreements with Google Cloud and our data center partners; variances in earnings on cash accounts and collateral that our clearing house holds for its clients; impact of CME Group pricing/fee level and structure and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings. For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the Securities and Exchange Commission ("SEC") on February 28, 2024, under the caption "Risk Factors."
CME Group Inc. and Subsidiaries | ||||
Consolidated Balance Sheets | ||||
(in millions) | ||||
December 31, 2024 | December 31, 2023 | |||
ASSETS | ||||
Current Assets: | ||||
Cash and cash equivalents | $ 2,892.4 | $ 2,912.0 | ||
Marketable securities | 113.2 | 111.7 | ||
Accounts receivable, net of allowance | 573.1 | 535.6 | ||
Other current assets (includes | 559.4 | 1,138.4 | ||
Performance bonds and guaranty fund contributions | 98,895.4 | 90,192.5 | ||
Total current assets | 103,033.5 | 94,890.2 | ||
Property, net of accumulated depreciation and amortization | 386.2 | 409.5 | ||
Intangible assets—trading products | 17,175.3 | 17,175.3 | ||
Intangible assets—other, net | 2,821.6 | 3,050.2 | ||
Goodwill | 10,486.9 | 10,495.3 | ||
Other assets | 3,543.5 | 3,685.6 | ||
Total Assets | $ 137,447.0 | $ 129,706.1 | ||
LIABILITIES AND EQUITY | ||||
Current Liabilities: | ||||
Accounts payable | $ 79.9 | $ 90.6 | ||
Short-term debt | 749.8 | — | ||
Other current liabilities | 2,588.8 | 3,133.8 | ||
Performance bonds and guaranty fund contributions | 98,895.4 | 90,192.5 | ||
Total current liabilities | 102,313.9 | 93,416.9 | ||
Long-term debt | 2,678.2 | 3,425.4 | ||
Deferred income tax liabilities, net | 5,246.8 | 5,327.7 | ||
Other liabilities | 721.2 | 798.2 | ||
Total Liabilities | 110,960.1 | 102,968.2 | ||
CME Group Shareholders' Equity | 26,486.9 | 26,737.9 | ||
Total Liabilities and Equity | $ 137,447.0 | $ 129,706.1 | ||
CME Group Inc. and Subsidiaries | ||||||||
Consolidated Statements of Income | ||||||||
(dollars in millions, except per share amounts; shares in thousands) | ||||||||
Quarter Ended December 31, | Year Ended December 31, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
Revenues | ||||||||
Clearing and transaction fees | $ 1,232.3 | $ 1,184.5 | $ 4,988.2 | $ 4,588.5 | ||||
Market data and information services | 181.6 | 167.2 | 710.2 | 663.7 | ||||
Other | 111.4 | 87.6 | 431.7 | 326.7 | ||||
Total Revenues | 1,525.3 | 1,439.3 | 6,130.1 | 5,578.9 | ||||
Expenses | ||||||||
Compensation and benefits | 220.8 | 212.9 | 850.3 | 828.6 | ||||
Technology | 65.7 | 58.5 | 255.8 | 218.7 | ||||
Professional fees and outside services | 33.9 | 36.1 | 132.7 | 144.4 | ||||
Amortization of purchased intangibles | 55.3 | 55.6 | 221.7 | 226.6 | ||||
Depreciation and amortization | 28.1 | 30.7 | 115.1 | 126.0 | ||||
Licensing and other fee agreements | 84.0 | 80.4 | 355.4 | 322.8 | ||||
Other | 90.4 | 101.9 | 267.6 | 276.1 | ||||
Total Expenses | 578.2 | 576.1 | 2,198.6 | 2,143.2 | ||||
Operating Income | 947.1 | 863.2 | 3,931.5 | 3,435.7 | ||||
Non-Operating Income (Expense) | ||||||||
Investment income | 936.5 | 1,076.9 | 4,079.1 | 5,275.3 | ||||
Interest and other borrowing costs | (40.7) | (39.7) | (160.9) | (159.4) | ||||
Equity in net earnings (losses) of unconsolidated | 91.2 | 66.8 | 350.9 | 296.9 | ||||
Other non-operating income (expense) | (837.5) | (961.2) | (3,659.2) | (4,694.9) | ||||
Total Non-Operating Income (Expense) | 149.5 | 142.8 | 609.9 | 717.9 | ||||
Income before Income Taxes | 1,096.6 | 1,006.0 | 4,541.4 | 4,153.6 | ||||
Income tax provision | 222.0 | 191.4 | 1,015.6 | 927.4 | ||||
Net Income | $ 874.6 | $ 814.6 | $ 3,525.8 | $ 3,226.2 | ||||
Net Income Attributable to Common Shareholders of | $ 863.7 | $ 804.3 | $ 3,481.5 | $ 3,185.6 | ||||
Earnings per Share Attributable to Common Shareholders of CME Group: | ||||||||
Basic | $ 2.40 | $ 2.24 | $ 9.69 | $ 8.87 | ||||
Diluted | 2.40 | 2.24 | 9.67 | 8.86 | ||||
Weighted Average Number of Common Shares: | ||||||||
Basic | 359,568 | 359,197 | 359,389 | 359,023 | ||||
Diluted | 360,050 | 359,693 | 359,944 | 359,500 | ||||
CME Group Inc. and Subsidiaries | ||||||||
Reconciliation of GAAP to non-GAAP Measures | ||||||||
(dollars in millions, except per share amounts; shares in thousands) | ||||||||
Quarter Ended December 31, | Year Ended December 31, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
Net Income | $ 874.6 | $ 814.6 | $ 3,525.8 | $ 3,226.2 | ||||
Restructuring and severance | 1.0 | 2.7 | 11.3 | 17.6 | ||||
Amortization of purchased intangibles(1) | 69.0 | 69.0 | 275.9 | 280.3 | ||||
Litigation matters or settlements | — | 8.5 | 1.2 | 10.5 | ||||
Strategic transaction-related costs | — | — | 0.8 | (2.2) | ||||
Real estate-related costs (credits) | — | — | (2.0) | — | ||||
Foreign exchange transaction (gains) losses | 0.7 | 13.0 | 2.9 | 12.9 | ||||
Unrealized and realized (gains) losses on investments | 8.1 | 4.7 | (3.6) | (67.1) | ||||
Unrealized and realized (gains) losses on assets | 0.1 | 0.9 | 0.9 | 1.3 | ||||
Income tax effect related to above | (15.9) | (15.5) | (57.2) | (44.1) | ||||
Other income tax items(2) | (18.7) | (33.2) | (16.8) | (34.0) | ||||
Adjusted Net Income | $ 918.9 | $ 864.7 | $ 3,739.2 | $ 3,401.4 | ||||
Adjusted Net Income Attributable to Common | $ 907.4 | $ 853.8 | $ 3,692.2 | $ 3,358.6 | ||||
Earnings per Share Attributable to Common Shareholders of CME Group: | ||||||||
Basic | $ 2.40 | $ 2.24 | $ 9.69 | $ 8.87 | ||||
Diluted | 2.40 | 2.24 | 9.67 | 8.86 | ||||
Adjusted Earnings per Share Attributable to Common Shareholders of CME Group: | ||||||||
Basic | $ 2.52 | $ 2.38 | $ 10.27 | $ 9.35 | ||||
Diluted | 2.52 | 2.37 | 10.26 | 9.34 | ||||
Weighted Average Number of Shares: | ||||||||
Basic common shares | 359,568 | 359,197 | 359,389 | 359,023 | ||||
Diluted common shares | 360,050 | 359,693 | 359,944 | 359,500 | ||||
Preferred shares(3) | 4,584 | 4,584 | 4,584 | 4,584 | ||||
1. Includes | ||||||||
2. Other income tax items include benefits recognized for the settlement of various tax audits and for changes in state and local deferred tax rates. | ||||||||
3. Preferred shares have similar rights as common shares without voting rights. |
CME Group Inc. and Subsidiaries | ||||||||||
Quarterly Operating Statistics | ||||||||||
4Q 2023 | 1Q 2024 | 2Q 2024 | 3Q 2024 | 4Q 2024 | ||||||
Trading Days | 63 | 61 | 63 | 64 | 64 | |||||
Quarterly Average Daily Volume (ADV)(1) | ||||||||||
CME Group ADV (in thousands) | ||||||||||
Product Line | 4Q 2023 | 1Q 2024 | 2Q 2024 | 3Q 2024 | 4Q 2024 | |||||
Interest rates | 13,348 | 13,839 | 12,894 | 14,881 | 13,244 | |||||
Equity indexes | 6,922 | 6,856 | 6,779 | 7,407 | 6,343 | |||||
Foreign exchange | 1,007 | 984 | 1,075 | 1,089 | 969 | |||||
Energy | 2,158 | 2,412 | 2,447 | 2,571 | 2,519 | |||||
Agricultural commodities | 1,469 | 1,596 | 1,877 | 1,614 | 1,755 | |||||
Metals | 609 | 675 | 868 | 728 | 673 | |||||
Total | 25,513 | 26,360 | 25,941 | 28,289 | 25,503 | |||||
Venue | ||||||||||
CME Globex | 23,503 | 23,985 | 24,143 | 26,199 | 23,684 | |||||
Open outcry | 1,126 | 1,333 | 825 | 1,096 | 848 | |||||
Privately negotiated | 885 | 1,043 | 974 | 994 | 971 | |||||
Total | 25,513 | 26,360 | 25,941 | 28,289 | 25,503 | |||||
Quarterly Average Rate Per Contract (RPC)(1) | ||||||||||
CME Group RPC | ||||||||||
Product Line | 4Q 2023 | 1Q 2024 | 2Q 2024 | 3Q 2024 | 4Q 2024 | |||||
Interest rates | $ 0.488 | $ 0.486 | $ 0.484 | $ 0.468 | $ 0.485 | |||||
Equity indexes | 0.616 | 0.641 | 0.628 | 0.616 | 0.658 | |||||
Foreign exchange | 0.806 | 0.787 | 0.754 | 0.744 | 0.778 | |||||
Energy | 1.338 | 1.334 | 1.297 | 1.246 | 1.237 | |||||
Agricultural commodities | 1.361 | 1.356 | 1.366 | 1.346 | 1.359 | |||||
Metals | 1.502 | 1.556 | 1.511 | 1.540 | 1.530 | |||||
Average RPC | $ 0.682 | $ 0.695 | $ 0.708 | $ 0.666 | $ 0.701 | |||||
1. ADV and RPC includes futures and options on futures only. |
CME-G
View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-all-time-record-annual-revenue-adjusted-operating-income-adjusted-net-income-and-adjusted-earnings-per-share-for-2024-302374213.html
SOURCE CME Group
FAQ
What was CME Group's total revenue for full-year 2024?
How much did CME Group pay in dividends during 2024?
What was CME's Q4 2024 earnings per share?
How much did CME Group increase its quarterly dividend for Q1 2025?
What was CME Group's average daily trading volume in Q4 2024?
